J.-T. Li et al. / Ultrasonics Sonochemistry 19 (2012) 1033–1038
1035
Table 1
The effect of reaction conditions on the yield of 2a under ultrasound irradiation.a
Entry
Frequency, kHz
Substrate/regent, molar ratio
DBSA, mmol
T, °C
Isolated yield, %
1
2
3
4
5
6
7
8
25
25
25
25
25
25
25
25
25
25
40
25
–
1:1.1
1:1.1
1:1.1
1:1.1
1:1.1
1:1.1
1:1.1
1:1.1
1:1
1:1.2
1:1.1
1:1.1
1:1.1
0.1
0.2
0.3
0.4
0.5
0.6
0.5
0.5
0.5
0.5
0.5
–
25–27
25–27
25–27
25–27
25–27
25–27
35–37
45–47
25–27
25–27
25–27
25–27
25–27
26
41
58
75
94
96
90
93
91
95
92
–
9
10
11
12
13
0.5
75
a
Reaction time: 2 h.
2.2.5. Compound 2e
CH2), 6.08 (s, 2H, CH2), 6.95 (d, J = 8 Hz, 1H, CH), 6.98–7.07 (m,
2H, Ph-H), 7.08 (d, J = 8 Hz, 1H, CH), 7.25 (d, J = 8 Hz, 1H, CH),
7.31 (d, J = 8 Hz, 1H, CH), 7.38 (s, 2H, NH2), 7.42–7.70 (m, 4H, Ph-
H), 7.75 (brs, 1H, NH), 11.67 (s, 1H, NH); 13C NMR: dC 156.4,
149.1, 148.4, 148.3, 148.2, 139.9, 135.4, 131.2, 130.6, 125.2,
123.5, 121.0, 116.2, 108.9, 106.9, 106.3, 101.9, 101.5; HRMS m/z
(ESI): calcd for C20H19N4O4 [M + H]+ 379.1401, found 379.1401.
2-{3-(4-methylphenyl)-1-[2-(4-methylphenyl)ethenyl]-2-
propen-1-ylidene}hydrazinecarboximidamide hydrochloride: yel-
low solid, m.p. 179–180 °C (179.5–180.5 °C) [6]. 1H NMR: dH 2.33
(s, 3H, CH3), 2.35 (s, 3H, CH3), 7.17 (d, J = 16 Hz, 1H, CH), 7.22–
7.28 (m, 4H, Ph-H), 7.29 (d, J = 16 Hz, 1H, CH), 7.40 (d, J = 16 Hz,
1H, CH), 7.49 (d, J = 16 Hz, 1H, CH), 7.57 (d, J = 8 Hz, 2H, NH2),
7.710–7.75 (m, 4H, Ph-H), 7.85 (brs, 1H, NH), 11.85 (s, 1H, NH).
2.2.10. Compound 2j
2-{3-(2,4-dichlorophenyl)-1-[2-(2,4-dichlorophenyl)ethenyl]-
2-propen-1-ylidene}-hydrazinecarboximidamide hydrochloride:
yellow solid, m.p. 187–188 °C. 1H NMR: dH 7.17 (d, J = 16 Hz, 1H,
CH), 7.42 (d, J = 16 Hz, 1H, CH), 7.46–7.53 (m, 4H, PH-h), 7.66 (s,
2H, NH2), 7.75–7.81(m, 2H, PH-h), 7.83 (brs, 1H, NH), 7.87 (d,
J = 8 Hz, 1H, CH), 8.29 (d, J = 8 Hz, 1H, CH), 11.97 (s, 1H, NH); 13C
NMR: dC 134.6, 133.9, 133.8, 133.5, 132.9, 132.5, 129.6, 129.3,
129.2, 128.0, 127.9, 127.9, 121.3. m/z (EI): 429.1 [M + H]+.
2.2.6. Compound 2f
2-{3-phenyl-1-[2-(4-methylphenyl)ethenyl]-2-propen-1-yli-
dene}-hydrazinecarboximidamide hydrochloride: yellow solid,
m.p. 183–184 °C. 1H NMR: dH 2.33 (s, 3H, CH3), 7.12 (d, J = 16 Hz,
1H, CH), 7.16–7.26 (m, 5H, Ph-H), 7.28 (d, J = 16 Hz, 1H, CH), 7.32
(d, J = 16 Hz, 1H, CH), 7.37 (d, J = 16 Hz, 1H, CH), 7.40 (d, J = 8 Hz,
2H, NH2), 7.50–7.62 (m, 4H, Ph-H), 7.65 (brs, 1H, NH), 11.62 (s,
1H, NH). 13C NMR: dC 153.4, 147.1, 139.2, 135.8, 129.8, 129.7,
129.1, 129.0, 127.6, 127.5, 127.1, 22.1; HRMS m/z (ESI): calcd for
C
19H21N4 [M + H]+ 305.1761, found 305.1764.
2.2.11. Compound 2k
2-{3-(3,4-dichlorophenyl)-1-[2-(3,4-dichlorophenyl)ethenyl]-
2-propen-1-ylidene}-hydrazinecarboximidamide hydrochloride:
yellow solid, m.p. 237–239 °C. 1H NMR: dH 7.33 (d, J = 16 Hz, 1H,
CH), 7.50 (d, J = 16 Hz, 1H, CH), 7.57 (d, J = 16 Hz, 1H, CH), 7.67–
7.70 (m, 3H, Ph-H), 7.72 (d, J = 16 Hz, 1H, CH), 7.88 (d, J = 8 Hz,
2H, NH2), 7.92 (brs, 1H, NH), 8.0–8.2 (m, 3H, Ph-H), 10.48 (s, 1H,
NH); 13C NMR: dC 137.8, 137.2, 132.3, 132.2, 131.1, 130.2, 129.3,
129.2, 128.4, 127.8, 120.3; m/z (EI): 429.1 [M + H]+.
2.2.7. Compound 2g
2-{3-phenyl-1-[2-(4-methoxylphenyl)ethenyl]-2-propen-1-yli-
dene}-hydrazinecarboximidamide hydrochloride: yellow solid;
m.p. 146–148 °C. 1H NMR: dH 3.80 (s, 3H, CH3), 7.24 (d, J = 16 Hz,
1H, CH), 7.31–7.44 (m, 6H, Ph-H), 7.45 (d, J = 16 Hz, 1H, CH), 7.52
(d, J = 8.4 Hz, 1H, CH), 7.63 (d, J = 8.4 Hz, 1H, CH), 7.68 (d,
J = 7.5 Hz, 2H, NH2), 7.78–7.84 (m, 3H, Ph-H), 7.87 (brs, 1H, NH),
11.97 (s, 1H, NH). 13C NMR: dC 160.9, 160.2, 156.5, 136.8, 130.2,
129.8, 129.1, 129.0, 128.5, 127.7, 123.1, 114.7, 55.8; HRMS m/z
(ESI): calcd for C19H21N4O [M + H]+ 321.1710, found 321.1712.
2.2.12. Compound 2l
2-{3-phenyl-1-[2-(4-chlorophenyl)ethenyl]-2-propen-1-yli-
dene}-hydrazinecarboximidamide hydrochloride: yellow solid,
m.p. 209–210 °C. 1H NMR: dH 7.27 (d, J = 16 Hz, 1H, CH), 7.33–
7.45 (m, 5H, Ph-H), 7.48 (d, J = 16 Hz, 1H, CH), 7.54 (d, J = 16 Hz,
1H, CH), 7.68 (d, J = 16 Hz, 1H, CH), 7.72 (d, J = 8 Hz, 2H, NH2),
7.81 (brs, 1H, NH), 7.86–7.92 (m, 4H, Ph-H), 11.95 (s, 1H, NH).
13C NMR: dC 156.3, 139.2, 136.8, 136.4, 135.7, 135.4, 134.5, 133.5,
130.5, 130.1, 129.5, 129.2, 128.5, 127.7, 119.0, 118.0; HRMS m/z
(ESI): calcd for C18H18ClN4 [M + H]+ 325.1214, found 325.1217.
2.2.8. Compound 2h
2-{3-(4-methoxyphenyl)-1-[2-(4-methoxyphenyl)ethenyl]-
2-propen-1-ylidene}-hydrazinecarboximidamide hydrochloride:
yellow solid, m.p. 208–209 °C. 1H NMR: dH 3.81 (s, 6H, CH3),
6.96–7.01 (m, 4H, Ph-H), 7.08 (d, J = 16 Hz, 1H, CH), 7.38 (d,
J = 16 Hz, 1H, CH), 7.42 (d, J = 16 Hz, 1H, CH), 7.46 (d, J = 16 Hz,
1H, CH), 7.63 (d, J = 8.6 Hz, 2H, NH2), 7.70 (brs, 1H, NH), 7.76–
7.86 (m, 4H, Ph-H), 11.83 (s, 1H, NH); 13C NMR: dC 160.9, 160.2,
156.0, 150.7, 139.2, 134.9, 130.2, 129.5, 129.2, 128.9, 120.6,
116.9, 114.6, 55.7, 55.8; HRMS m/z (ESI): calcd for C20H23N4O2
[M + H]+ 351.1816, found 351.1818.
3. Results and discussion
To optimize the reaction conditions, the condensation of 1,5-di-
phenyl-1,4-pentadien-3-one (1a) and aminoguanidine hydrochlo-
ride was selected as the model under ultrasound irradiation
(Table 1).
The effect of the amount of DBSA on the reaction was observed.
When the amount of DBSA was 0.1 mmol, 0.2 mmol, 0.3 mmol,
2.2.9. Compound 2i
2-{3-(3,4-dioxanemethylphenyl)-1-[2-(3,4-dioxanemethylphenyl)
ethenyl]-2-propen-1-ylidene}-hydrazinecarboximidamide hydro-
chloride: yellow solid, m.p. 234–235 °C. 1H NMR: dH 6.06 (s, 2H,